M2GEN is an oncology-focused informatics solutions company advancing precision medicine and transforming cancer care through linked clinical and deep molecular data. In collaboration with leading academic cancer centers, biopharmaceutical companies and patients, we have developed a unique data-driven ecosystem to provide cancer researchers and clinicians with insights to make informed decisions faster. We focus on the areas of greatest unmet need in oncology, including hematological malignancies. For more information, visit www.M2GEN.com.